alpha-aminopyridine has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arner, EN; Brekken, RA; Cruz, VH; Scherer, PE; Wynne, KW | 1 |
| Beno, DW; Liu, B; Liu, G; Liu, M; Lubbers, NL; Polakowski, JS; Serby, MD; Sham, HL; Trevillyan, JM; Widomski, DL; Xin, Z; Zhao, H | 1 |
2 other study(ies) available for alpha-aminopyridine and Metabolic Diseases
| Article | Year |
|---|---|
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Topics: Aminopyridines; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Fatty Liver; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Weight Loss | 2018 |
Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.
Topics: Aminopyridines; Anesthesia; Anesthetics; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; MAP Kinase Kinase 4; Metabolic Diseases; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiopental; Vascular Resistance; Ventricular Function, Left | 2007 |